Apellis Pharmaceuticals Inc (APLS) Earning Prediction
Apellis Pharmaceuticals Inc (APLS) is set to release its earnings performance on 02/24 07:05:00 ET in Pre-Market trading. Consensus forecasts predict a revenue of 194.37M and an earnings per share (EPS) of -0.39 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
APLS Transcript
The earnings call highlights significant production growth, record revenue, and strong cash flow, indicating robust financial performance. Despite elevated costs due to expansion, the company achieved cost efficiencies and maintained a strong cash position. The Q&A session revealed positive operational progress and no major concerns from analysts. Given these factors, along with optimistic guidance and strong financial metrics, the stock price is likely to experience a positive movement in the next two weeks.
The earnings call summary highlights strategic growth initiatives for SYFOVRE and EMPAVELI, with plans for market expansion and product development. While financial guidance is stable, new tools and education initiatives indicate a positive outlook. The Q&A session reveals optimism about market leadership and innovation, though some uncertainty exists around specific metrics. Overall, the strategic focus on growth and market expansion, coupled with a commitment to supporting patient access, suggests a positive sentiment, likely leading to a stock price increase in the short term.
APLS Slides
APLS Report
Frequently Asked Questions
What is the Apellis Pharmaceuticals Inc {quarter} Earnings Release Date and Time?
Apellis Pharmaceuticals Inc (APLS) is scheduled to release its {quarter} earnings report on Feb 24, 2026, Pre-Market (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Apellis Pharmaceuticals Inc {quarter} Revenue and EPS?
Analysts' consensus predicts 194.37M in revenue and an EPS of -0.39 for Apellis Pharmaceuticals Inc's {quarter}.
What Does Intellectia's AI Predict for Apellis Pharmaceuticals Inc {quarter} Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Apellis Pharmaceuticals Inc's {quarter} earnings, with a prediction date of Feb 24, 2026. Apellis Pharmaceuticals Inc {summary}
How Can I Use This Earnings Prediction to Trade APLS Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Feb 24, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Apellis Pharmaceuticals Inc {quarter}?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
